Robert Henry is leading another healthcare turnaround success story as Chief Executive Officer at Pierian Biosciences where he is applying his experience in growing, building, and rejuvenating healthcare companies.
He joined Pierian Biosciences (formerly DiaTech Oncology) in 2013 to take the company to the next level in the personalized cancer care market. He brought more than twenty-five years of healthcare management experience in developing, implementing, and evaluating new opportunities in managed care. He has excelled as a business development leader, president, CEO, and board member with extensive qualifications in operational and financial management, management restructuring, contract negotiations, and international governance.
Previously, he served as SVP of Development at Symbion, Inc., President and Chief Executive Officer of American Endoscopy Services, and Chief Operating Officer of Physician Alliances.
Henry holds an MBA from the Owen Graduate School of Management at Vanderbilt University and a BS in Business Administration-Finance from the University of Tennessee.
Norman Purvis, PhD, is a scientist and entrepreneur. With ten patents and dozens of published articles, he is well recognized as a thought leader in quantitative fluorescence techniques and standardization practices for high complexity flow cytometric assay design, validation, and implementation.
Leveraging his years of experience in academia and business, he is well-versed in bringing commercially viable products to market.
Dr. Purvis joined Pierian Biosciences with a specialization in developing custom quantitative assays to support drug discovery and clinical trials. He brings with him the knowledge of implementing new technologies while adhering to GLP and CLIA regulatory requirements.
As an experienced leader managing cross-functional teams, he has played pivotal roles at many biopharma companies including Nodality and IncellDx, directing manufacturing personnel, research associates, and scientists in support of R&D.
Purvis received a BS in Biological Engineering (with honors) from Mississippi State University and an MS in Biomedical Engineering from Vanderbilt University, where he also earned a doctorate in Chemical Engineering.